Genzyme Transgenics Corp.'s cloning of three female goats that produce human antithrombin III in their milk could allow the company to rapidly scale up commercial production of the protein. ATIII is in Phase III testing to improve patient response to heparin during coronary artery bypass surgery (CABG) and could be the first transgenically produced protein to reach the market (see chart below).

"The animals we're working with now